Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
HIV integrase inhibitor.
Endogenous neuropeptide, involved in opioid sig...
Alkylphospholipid analog; Akt inhibitor.
Nicotinamide analog prodrug; fatty acid synthet...
STING agonist
Endogenous steroid hormone involved in reproduc...
Synthetic ITC, erysolin analog.
PDGFR inhibitor.
Optically active isomer of ibuprofen, NSAID; CO...
Dihydropyridine, FIASMA; L-type Ca2+ channel bl...
Glycopeptide, vancomycin analog; peptidoglycan ...
Polymer precursor
Vitamin E component
Fibrate; PPARα agonist.
S-isomer of omeprazole; H+/K+ ATPase inhibitor....
Serotonin/melatonin analog found in various pla...
Peptide, carbonic anhydrase G250 epitope.
Third generation macrocyclic ALK inhibitor.
NPC1L1 inhibitor.
Endogenous calcitonin-family peptide, involved ...